Optimisation and validation of a conventional elisa and cut-offs for detecting and quantifying anti-sars-cov-2 spike, rbd, and nucleoprotein igg, igm, and iga antibodies in uganda

HIGHLIGHTS

• who: Gerald Kevin Oluka and colleagues from the University of Siena, Italy have published the paper: Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda, in the Journal: (JOURNAL)
• what: The authors aimed to develop, optimise, and validate an inhouse indirect ELISA for detecting and quantifying antibodies directed against the SARS-CoV-2 spike, RBD and nucleoprotein for the Ugandan population and similar settings in Sub-Saharan Africa.
• how: The authors chose to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.